Cargando…

5610107 LIVE OUTCOMES AND BIOMETRIC MONITORING: POTENTIAL IMPLICATIONS FOR PATIENT QUALITY OF LIFE IN SICKLE CELL DISEASE

Detalles Bibliográficos
Autores principales:	Agrippa, O.A., Summers, K.Z., Anie, K.A., Telfer, P., Lugthart, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	e-Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112621/ http://dx.doi.org/10.1097/01.HS9.0000928576.41168.0a

Ejemplares similares

5609968 REAL-WORLD PATIENT-REPORTED OUTCOMES AND WEARABLE METRIC CORRELATIONS: REMOTE DAILY MONITORING FOR EXPLORATION OF QUALITY OF LIFE IN SICKLE CELL DISEASE
por: Agrippa, O.A., et al.
Publicado: (2023)

P1441: REAL-WORLD OUTCOMES AND DIGITALLY MONITORED QUALITY OF LIFE IN CRIZANLIZUMAB-TREATED PATIENTS WITH SICKLE CELL DISEASE.
por: Summers, Kim, et al.
Publicado: (2023)

P1448: CHARACTERISATION OF QUALITY OF LIFE-LINKED PATIENT-REPORTED OUTCOMES THROUGH A DIGITAL AND CONTINUOUS REMOTE MONITORING ECOSYSTEM IN SICKLE CELL DISEASE.
por: Summers, Kim, et al.
Publicado: (2023)

P-037: EXPLORATION OF THE REAL-WORLD IMPACTS OF SLEEP UPON QUALITY OF LIFE IN PATIENTS WITH SICKLE CELL DISEASE
por: O., AGRIPPA, et al.
Publicado: (2022)

P131: REAL-TIME VACCINATION IMPACTS IN SICKLE CELL DISEASE: A REAL-WORLD PATIENT CASE STUDY FOR INFLUENZA AND COVID-19 VACCINATION
por: Agrippa, O, et al.
Publicado: (2022)

S110: ACUTE AND CHRONIC PAIN MANAGEMENT IN SICKLE CELL DISEASE: OUTCOMES OF AN ENGLISH NATIONAL AUDIT.
por: Lugthart, S, et al.
Publicado: (2022)

5613514 PAVING THE WAY FOR GENETIC MEDICINE IN SUB-SAHARAN AFRICA: A REPORT ON THE FIRST GENETIC COUNSELLING PROGRAM IN THE REGION
por: Osae-Larbi, J.A., et al.
Publicado: (2023)

5610178 SURVIVAL AND COMPLICATIONS IN PATIENTS WITH HEMOGLOBINOPATHIES: THE EXPERIENCE OF A SINGLE DEPARTMENT OF THALASSEMIA AND SICKLE DISEASE
por: Xydaki, X.A., et al.
Publicado: (2023)

5597199 AGEING WITH SICKLE CELL ANEMIA AND HOW TO FACE IT
por: Kreka, M.K., et al.
Publicado: (2023)

5610603 CLINICAL AND GENETIC PREDICTORS OF SICKLE CELL NEPHROPATHY IN MALAWI
por: Banda, K.H.B., et al.
Publicado: (2023)

5613341 REAL-WORLD CHANGES IN KIDNEY FUNCTION FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANAEMIAS RECEIVING IRON CHELATION THERAPY IN THE US
por: Sunil Bhandari, S.B., et al.
Publicado: (2023)

5596737 RETINOPATHY IN EGYPTIAN PATIENTS WITH SICKLE CELL DISEASE
por: Hassan, T.H., et al.
Publicado: (2023)

5613019 THE CO-EXISTENCE OF SICKLE CELL DISEASE WITH NEUROFIBROMATOSIS: A CASE REPORT
por: Crombie, K., et al.
Publicado: (2023)

5613401 SICKLE CELL DISEASE GENOMICS OF AFRICA (SICKLEGENAFRICA) NETWORK: QUALITATIVE INTERVIEW FINDINGS ON REASONS FOR REFUSAL OF BROAD CONSENT
por: Osae-Larbi, J.A., et al.
Publicado: (2023)

5613165 INVESTIGATING VARIANTS ASSOCIATED WITH QUANTITATIVE RED BLOOD CELL PHENOTYPES FROM TOPMED PREDICTIONS IN AFRICAN SICKLE CELL DISEASE POPULATIONS.
por: Samie, N., et al.
Publicado: (2023)

5567917 COST COMPARISON OF TRANSFUSION CHOICES IN OMAN FOR PATIENTS SUFFERING FROM SICKLE CELL DISEASE
por: Sweerts, L., et al.
Publicado: (2023)

5613251 RAPIDLY PROGRESSING MOYAMOYA SYNDROME IN SICKLE CELL DISEASE -- CASE REPORT
por: Joana, J.L., et al.
Publicado: (2023)

5566409 IMPACT OF GENETIC VARIATIONS ON THROMBOTIC RISK OF SICKLE CELL DISEASE IN SAUDI PATIENTS
por: Alshabeeb, M.A., et al.
Publicado: (2023)

5597164 BURDEN AND RISK FACTOR TO ACUTE MYOCARDIAL ISCHAEMIA IN CHILDREN WITH SICKLE CELL ANAEMIA
por: Adeniyi, O.D., et al.
Publicado: (2023)

5613458 BLOOD MICROPARTICLES: A TOOL OF EVALUATING THE EFFECT OF TRANSFUSION IN SICKLE CELL DISEASE PATIENTS
por: Khalfaoui, K., et al.
Publicado: (2023)

5612390 CORRELATION OF DOPPLER DEFINED ELEVATED PULMONARY PRESSURE WITH LABORATORY PARAMETERS IN ADULT PATIENTS WITH SICKLE CELL DISEASE - A RETROSPECTIVE STUDY
por: Samal, P.S.S., et al.
Publicado: (2023)

5610131 A STANDARDISED LANGUAGE TAG PROTOCOL AND WORKFLOW FOR DEVELOPING AND MANAGING MULTILINGUAL ONTOLOGIES: SHOWCASING THE FRENCH SICKLE CELL DISEASE ONTOLOGY (SCDO)
por: Hotchkiss, J., et al.
Publicado: (2023)

5589865 PRELIMINARY FINDINGS FROM THE FOLLOW-UP OF PREGNANT SICKLE CELL DISEASE PATIENTS IN LUANDA, ANGOLA.
por: Brito, M., et al.
Publicado: (2023)

5597311 THE EFFECT OF MUSIC AND DANCE AS FORMS OF PHYSICAL ACTIVITY ON THE HEALTH STATUS OF PEOPLE WITH SICKLE CELL DISEASE: A SYSTEMATIC REVIEW OF THE LITERATURE
por: Van Gerven, A., et al.
Publicado: (2023)

5607225 ADDITION OF THERAPEUTIC PLASMA EXCHANGE TO RED CELL EXCHANGE IMPROVES OUTCOMES OF FAT EMBOLISM SYNDROME IN SICKLE CELL DISEASE
por: Tsitsikas, D.A., et al.
Publicado: (2023)

5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT
por: Levin, C.L., et al.
Publicado: (2023)

5607560 AN AUDIT OF COMPLIANCE WITH NEONATAL SCREENING GUIDELINES IN NEONATES DIAGNOSED WITH SICKLE CELL DISEASE IN SOUTH WALES
por: Pasha, S.R.P., et al.
Publicado: (2023)

5610614 ASSESSING PHYSICAL, SOCIAL AND EMOTIONAL IMPACT OF SICKLE CELL DISEASE IN PORTUGUESE PATIENTS: AN OBSERVATIONAL, MULTICENTER STUDY (ASCEND)
por: Christopher Saunders, C.S., et al.
Publicado: (2023)

5588995 COMPARATIVE EFFICACY AND SAFETY OF PHARMACOLOGICAL INTERVENTIONS FOR SICKLE CELL DISEASE IN CHILDREN AND ADOLESCENTS: A NETWORK META-ANALYSIS
por: Tonin, F.S., et al.
Publicado: (2023)

P-021: THE LIVING WELL WITH SICKLE CELL MOBILE APPLICATION
por: A., MATTHEWS, et al.
Publicado: (2022)

5613386 CELEBRATING THE SICKLE CELL DISEASE WORLD DAY ON JUNE 19TH AFTER TWO YEARS OF PANDEMIC: MY LIFE WITH SCD, PATIENTS’ PERSPECTIVE
por: Maran, J.E.M., et al.
Publicado: (2023)

P-001: COMMON DATA MODEL FOR SICKLE CELL DISEASE SURVEILLANCE: CONSIDERATIONS AND IMPLICATIONS
por: M., SMELTZER, et al.
Publicado: (2022)

5575938 DIETARY PATTERN, SOCIO-DEMOGRAPHIC CHARACTERISTICS AND NUTRITIONAL STATUS OF PREGNANT WOMEN ATTENDING BARAU DIKKO TEACHING HOSPITAL AND THE NEED TO DEVELOP RECOMMENDED DIETARY ALLOWANCE AND DIETARY REFERENCE INTAKES FOR SICKLE CELL DISEASE PATIENTS
por: Sunday, A.D.S., et al.
Publicado: (2023)

5588568 ASSOCIATION OF MANNOSE-BINDING LECTIN SERUM LEVEL AND PROMOTER GENE VARIANTS RS7096206 AND RS10031251 WITH FREQUENCY OF VASO-OCCLUSIVE EVENTS IN SICKLE CELL DISEASE PATIENTS; AN EGYPTIAN CROSS-SECTIONAL STUDY
por: El-Ghamrawy, M., et al.
Publicado: (2023)

Editorial: Biometric monitoring of emotions and behaviors
por: López, Antonio M., et al.
Publicado: (2022)

Liver and spleen biometrics in childhood-onset systemic lupus erythematosus patients
por: Guariento, Andressa, et al.
Publicado: (2014)

5612560 A MONITORING AND EVALUATION FRAMEWORK AND ASSOCIATED TOOLS FOR THE SICKLEINAFRICA CONSORTIUM
por: Nembaware, V., et al.
Publicado: (2023)

Methodological aspects of the oxygenscan in sickle cell disease: A need for standardization
por: Rab, Minke A.E., et al.
Publicado: (2019)

5613396 DIFFERENCE IN HOSPITALIZATIONS AND ANNUAL BED DAYS FOR PATIENTS WITH SICKLE CELL DISEASE BY VARYING LEVELS OF ANEMIA: A RETROSPECTIVE ANALYSIS OF LINKED PRIMARY AND SECONDARY CARE DATABASES IN ENGLAND
por: Telfer, P., et al.
Publicado: (2023)

5613294 BASELINE PATIENT CHARACTERISTICS FROM A UK EARLY ACCESS TO MEDICINES SCHEME (EAMS) WITH VOXELOTOR, A HBS POLYMERIZATION INHIBITOR, FOR THE TREATMENT OF HEMOLYTIC ANEMIA DUE TO SICKLE CELL DISEASE
por: Eleftheriou, P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a4apoj5u6gnbmoplvn5dl72hr1